CRMD : Summary for CorMedix Inc Common Stock - Yahoo Finance

U.S. Markets closed

CorMedix, Inc. (CRMD)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
1.74-0.07 (-3.87%)
At close: 4:02 PM EST
People also watch:
ZIOPSYNFCSCAXNANTH
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.81
Open1.80
Bid1.00 x 1000
Ask1.99 x 500
Day's Range1.71 - 1.83
52 Week Range1.15 - 4.54
Volume92,284
Avg. Volume383,756
Market Cap70.12M
Beta1.53
PE Ratio (TTM)-2.89
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to CorMedix, Inc. : December 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to CorMedix, Inc. Here are 5 ETFs with the largest exposure to CRMD-US. Comparing the performance and risk of CorMedix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube26 days ago

    ETFs with exposure to CorMedix, Inc. : November 14, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to CorMedix, Inc. Here are 5 ETFs with the largest exposure to CRMD-US. Comparing the performance and risk of CorMedix, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • CorMedix, Inc. :CRMD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016
    Capital Cube29 days ago

    CorMedix, Inc. :CRMD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016

    Categories: Yahoo Finance Get free summary analysis CorMedix, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of CorMedix, Inc. – Becton, Dickinson and Company, Emergent BioSolutions Inc., Utah Medical Products, Inc., Tetraphase Pharmaceuticals, Inc. and Achaogen, Inc. (BDX-US, EBS-US, UTMD-US, TTPH-US and AKAO-US) that have also ... Read more (Read more...)